Is Nourish profitable in 2026?

CEO Aidan Dewar said Nourish became profitable in 2025, a claim made public alongside its May 19, 2026 Series C announcement. No audited financials have been released to confirm this independently, but it was cited as a factor supporting the $1.75B valuation from Menlo Ventures.

How much funding has Nourish raised?

Nourish has raised $215M total as of May 19, 2026, including a $100M Series C at a $1.75B valuation led by Menlo Ventures. Prior rounds included a $70M Series B (April 2025) and $35M Series A (March 2024).

Who is Nourish's biggest competitor?

Fay and Berry Street are Nourish's closest rivals, both running the same insurance-covered telenutrition model. Both raised $50M in 2025 and, unlike Nourish, secured placement on Amazon's Health Benefits Connector, an employer-distribution channel Nourish lacked as of May 2026.

Could AI replace Nourish's dietitians?

Not the core service. Nourish's model depends on licensed Registered Dietitians and, since 2026, physicians billing insurance directly, a regulated clinical role AI cannot substitute for. Nourish does use AI for admin tasks and coaching support, reaching hundreds of thousands of monthly active users as of May 2026.

Nourish is privately held and venture-backed, with no acquisition or ownership change reported. Its Series C, closed May 19, 2026, was led by Menlo Ventures, whose partner J.P. Sanday joined the board; prior investors include Index Ventures, J.P. Morgan Growth Equity Partners, and Thrive Capital.

What is Nourish's valuation in 2026?

Nourish was valued at $1.75B following its $100M Series C round, announced May 19, 2026 and led by Menlo Ventures. This is up from a valuation reported as 'over $1B' at its April 2025 Series B.

United States · United States

Nourish

Nourish matches patients with insurance-covered dietitians for nutrition and chronic disease care.

Defensible for now

Assessed 29 July 2026 · Evidence as of 29 July 2026

Real protection, with named pressure against it.

On the recordSince 29 July 2026 · Checkable from Q3 2026 · Every call on the record Checkpoint: Amazon Health Benefits Connector placement status and GLP-1 physician launch execution review

The call

Nourish leads on network size and payer reach, but Fay and Berry Street are matching its model and gaining a distribution edge through Amazon that Nourish currently lacks.

Nourish hires registered dietitians to deliver personalized nutrition coaching to patients covered by health insurance plans and hospital systems. It is hard to copy quickly because it requires hiring and training thousands of licensed dietitians, securing contracts with insurance companies and hospitals, and navigating medical billing rules, which takes time and money. However, two similar competitors called Fay and Berry Street raised the same amount of funding recently and got placed on Amazon's health benefits marketplace, where employers shop for employee health programs, while Nourish did not make that cut. If Amazon's marketplace becomes where most employers buy health services, Nourish's direct deals with insurance companies may matter less, and the race could shift in favor of whoever has the best shelf space there.

Why

AI pressure: None apparent. Pure-AI nutrition coaching can't bill insurance or bear liability, so Nourish uses AI as a tool, not a replacement for its RDs. Could AI do the core job? Unlikely.

Bigger players: Fay and Berry Street, both placed on Amazon's Health Benefits Connector. Fay and Berry Street run the same RD-plus-payer model and now sit inside Amazon's benefits channel while Nourish does not. Could a giant copy it? Probably.

What protects it. 10,000+ contracted RDs, contracts covering 200M+ lives, and referral ties to 250+ health systems that a new entrant can't quickly copy.

What would change this call

Whether Fay or Berry Street appear on Amazon's Health Benefits Connector while Nourish remains absent. Would show rivals capturing a major distribution channel Nourish cannot access.
Nourish's May 2026 physician plus GLP-1 prescribing launch clears its waitlist without regulatory setbacks. Would show Nourish executing its next growth phase versus stalling under scrutiny.
Any payer publicly narrows or drops nutrition or GLP-1 support reimbursement. Would show the payer-contracting moat weakening industry-wide.

Key numbers

$100M Series C at $1.75B valuation (2026-05-19)
RD network grew to 10,000+ dietitians (2026-05-19)
Payer contracts cover 200M+ lives (2026-05-19)

Named risks

Excluded from Amazon Health Benefits Connector while Fay and Berry Street secured placement. Severity: high
May 2026 GLP-1 physician prescribing launch is waitlisted and faces regulatory scrutiny of virtual prescribing. Severity: medium
2025 profitability claim is company-stated and unaudited, not third-party verified. Severity: medium
Any payer reimbursement policy shift on nutrition or GLP-1 support would directly hit business model. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
Fay	gaining on	Joined Amazon Health Benefits Connector Sept 2025, raised $50M at reported $500M valuation, late 2025
Berry Street	gaining on	Raised $50M in 2025 and joined Amazon Health Benefits Connector, Nourish absent as of May 2026
Teladoc Health, Omada Health, Amwell	contesting	Broader virtual-care incumbents not yet shipped nutrition/GLP-1 bundled offering as of May 2026
Noom	contesting	Adjacent digital weight-loss/behavior coaching competitor in same GLP-1-driven demand space

Questions people ask

Is Nourish profitable in 2026?: CEO Aidan Dewar said Nourish became profitable in 2025, a claim made public alongside its May 19, 2026 Series C announcement. No audited financials have been released to confirm this independently, but it was cited as a factor supporting the $1.75B valuation from Menlo Ventures.
How much funding has Nourish raised?: Nourish has raised $215M total as of May 19, 2026, including a $100M Series C at a $1.75B valuation led by Menlo Ventures. Prior rounds included a $70M Series B (April 2025) and $35M Series A (March 2024).
Who is Nourish's biggest competitor?: Fay and Berry Street are Nourish's closest rivals, both running the same insurance-covered telenutrition model. Both raised $50M in 2025 and, unlike Nourish, secured placement on Amazon's Health Benefits Connector, an employer-distribution channel Nourish lacked as of May 2026.
Could AI replace Nourish's dietitians?: Not the core service. Nourish's model depends on licensed Registered Dietitians and, since 2026, physicians billing insurance directly, a regulated clinical role AI cannot substitute for. Nourish does use AI for admin tasks and coaching support, reaching hundreds of thousands of monthly active users as of May 2026.
Who owns Nourish?: Nourish is privately held and venture-backed, with no acquisition or ownership change reported. Its Series C, closed May 19, 2026, was led by Menlo Ventures, whose partner J.P. Sanday joined the board; prior investors include Index Ventures, J.P. Morgan Growth Equity Partners, and Thrive Capital.
What is Nourish's valuation in 2026?: Nourish was valued at $1.75B following its $100M Series C round, announced May 19, 2026 and led by Menlo Ventures. This is up from a valuation reported as 'over $1B' at its April 2025 Series B.

Timeline

2026-05-21Rebranded visual identity to 'The Bloom'
2026-05-19Raised $100M Series C at $1.75B valuation, led by Menlo Ventures
2026-05-19Announced expansion into metabolic health clinic with physicians and GLP-1 prescribing
2025-09-15Rival Fay joined Amazon's Health Benefits Connector
2025-04-23Closed $70M Series B led by J.P. Morgan Growth Equity Partners, valuation over $1B
2025-04Launched Nourish Clinical Outcomes Model for continuous outcomes measurement
2024-03Closed $35M Series A led by Index Ventures
2023-02Closed ~$8M Seed round led by Thrive Capital and Y Combinator

Revision history

29 July 2026

First assessed. Defensible for now. The text above is fixed as of this date and is not edited afterwards.

In the same band

UPS Block Broadcom